A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells.
- Published In:
- Journal of inorganic biochemistry, 212, 111214 (2020)
- Authors:
- Barrabés, Sílvia, Ng-Choi, Iteng, Martínez, María Ángeles, Manzano, Blanca R, Jalón, Félix A, Espino, Gustavo, Feliu, Lidia, Planas, Marta, de Llorens, Rafael, Massaguer, Anna
- Database ID:
- RPEP-04651
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04651APA
Barrabés, Sílvia; Ng-Choi, Iteng; Martínez, María Ángeles; Manzano, Blanca R; Jalón, Félix A; Espino, Gustavo; Feliu, Lidia; Planas, Marta; de Llorens, Rafael; Massaguer, Anna. (2020). A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells.. Journal of inorganic biochemistry, 212, 111214. https://doi.org/10.1016/j.jinorgbio.2020.111214
MLA
Barrabés, Sílvia, et al. "A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells.." Journal of inorganic biochemistry, 2020. https://doi.org/10.1016/j.jinorgbio.2020.111214
RethinkPeptides
RethinkPeptides Research Database. "A nucleus-directed bombesin derivative for targeted delivery..." RPEP-04651. Retrieved from https://rethinkpeptides.com/research/barrabes-2020-a-nucleusdirected-bombesin-derivative
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.